Trial
NCT06771921
A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Genmab
Collaborators
—
Condition
Malignant Solid Tumor
Intervention
GEN1078
Why stopped
The sponsor has made the decision to terminate further development of GEN1078 based on emerging safety observations and overall benefit-risk assessment of 1078
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-30